Heegaard Niels H H, Østergaard Ole, Bahl Justyna M C, Overgaard Martin, Beck Hans C, Rasmussen Lars Melholt, Larsen Martin R
Department of Clinical Biochemistry, Immunology & Genetics, Statens Serum Institut, Copenhagen, Denmark; Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark.
Proteomics Clin Appl. 2015 Feb;9(1-2):235-52. doi: 10.1002/prca.201400137. Epub 2015 Jan 22.
In the realm of clinical chemistry, the field of clinical proteomics, that is, the application of proteomic methods for understanding mechanisms and enabling diagnosis, prediction, measurement of activity, and treatment response in disease, is first and foremost a discovery and research tool that feeds assay development downstream. Putative new assay candidates generated by proteomics discovery projects compete with well-established assays with known indications, well-described performance, and of known value in specific clinical settings. Careful attention to the many options available in the design, execution, and interpretation of clinical proteomics studies is thus necessary for translation into clinical practice. We here review and discuss important options associated with clinical proteomics endeavors stretching from the planning phases to the final use in clinical chemistry.
在临床化学领域,临床蛋白质组学领域,即应用蛋白质组学方法来理解疾病机制并实现疾病诊断、预测、活性测量及治疗反应评估,首先是一种为下游检测方法开发提供依据的发现和研究工具。蛋白质组学发现项目产生的潜在新检测方法候选物,要与在特定临床环境中有已知适应症、性能描述详尽且价值明确的成熟检测方法展开竞争。因此,要将临床蛋白质组学研究转化为临床实践,就必须仔细关注临床蛋白质组学研究设计、实施及解读中的众多可用选项。我们在此回顾并讨论与临床蛋白质组学工作相关的重要选项,这些工作涵盖从规划阶段到临床化学最终应用的整个过程。